| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kaempferol = dietary flavonol polyphenol (aglycone; often present as glycosides such as kaempferol-3-O-glucoside). Sources: tea, kale, spinach, capers, broccoli, onions. Primary mechanisms (ranked): Pathways: -Inhibit the PI3K/Akt signaling -Modulation of the MAPK pathway (including ERK1/2) -Inhibit NF-κB Signaling Pathway -can upregulate or activate p53-dependent pathways -Inhibitory action on STAT -Activation of AMPK -Reduce VEGF -Can induce oxidative stress in cancer cells (ROS) Kaempferol — Cancer vs Normal Pathway Effects
TSF legend: P: 0–30 min | R: 30 min–3 hr | G: >3 hr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Source: HalifaxProj(inhibit) |
| Type: |
| NF-kB signaling Nuclear factor kappa B (NF-κB) is a transcription factor that plays a crucial role in regulating immune response, inflammation, cell proliferation, and survival. NF-κB is often found to be constitutively active in many types of cancer cells. This persistent activation can promote tumorigenesis by enhancing cell survival, proliferation, and metastasis. |
| 3372- | QC, | FIS, | KaempF, | Anticancer Potential of Selected Flavonols: Fisetin, Kaempferol, and Quercetin on Head and Neck Cancers |
| - | Review, | HNSCC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:316 Target#:214 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid